ArticleCureus2026

Real-World Functional and Anatomical Outcomes of Intravitreal Faricimab in Suboptimal Responders With Neovascular Age-Related Macular Degeneration: A 24-Month Clinical Audit.

Dhanya Sukumaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.